Serum leptin: A marker of prostate cancer irrespective of obesity

Cancer Biomarkers

Volumn 7, Issue 1, 2010, Pages 11-15

  Singh, S K ^a   Grifson, J J ^a   Mavuduru, R S ^a   Agarwal, M M ^a   Mandal, A K ^a   Jha, V ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

body mass index; carcinoma prostate; Leptin; obesity; waist hip ratio

Indexed keywords

LEPTIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLEASON SCORE; HORMONE BLOOD LEVEL; HUMAN; INDIAN; MALE; OBESITY; PRIORITY JOURNAL; PROSTATE CARCINOMA; WAIST HIP RATIO;

AGED; BODY MASS INDEX; HUMANS; INDIA; LEPTIN; MALE; MIDDLE AGED; OBESITY; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; WAIST-HIP RATIO;

EID: 78149236520     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2010-0136     Document Type: Article

References (21)

1. G. Aus, C.C. Abbou, M. Bolla et al., EAU guidelines on prostate cancer, Eur Urol 48 (2005), 546-551.
2. M. Vercelli, A. Quaglia, E. Marani and S. Parodi. Prostate cancer incidence and mortality trends among elderly and adult Europeans, Crit Rev Oncol Hematol 35 (2000), 133-144.
3. Y.S. Pu, H.S. Chiang, C.C. Lin, C.Y. Huang, K.H. Huang and J. Chen, Changing trends of prostate cancer in Asia, Aging Male 7 (2004), 120-132.
4. S.J. Freedland, E. Giovannucci and E.A. Platz, Are findings from studies of obesity and prostate cancer really in conflict? Cancer Causes Control 17 (2006), 5-9.
5. M.A.Pelleymounter, M.J. Cullen, M.B. Baker et al., Effects of the obese gene product on body weight regulation in OB/OB mice, Science 269(5223) (1995), 540-543.
6. P. Stattin, S. S̈oderberg, G. Hallmans et al., Leptin is associated with increased prostate cancer risk: a nested case-referent study, Journal of Clinical Endocrinology &Metabolism 86(3) (2001), 1341-1345.
7. S. Chang, S.D. Hursting, J.H. Contois et al., Leptin and prostate cancer, Prostate 46(1) (2001), 62-67.
8. W. Hsing, S. Chua, Jr., Y.-T. Gao et al., Prostate cancer risk and serum levels of insulin and leptin: a population-based study, Journal of the National Cancer Institute 93(10) (2001), 783-789.
9. P. Stattin, R. Kaaks, R. Johansson et al., Plasma leptin is not associated with prostate cancer risk, Cancer Epidemiology Biomarkers & Prevention 12(5) (2003), 474-475.
10. S.J. Freedland, L.J. Sokoll, L.A. Mangold et al., Serum leptin and pathological findings at the time of radical prostatectomy, Journal of Urology 173(3) (2005), 773-776.
11. P. Somasundar, D.W. McFadden, S.M. Hileman and L. Vona-Davis, Leptin is a growth factor in cancer, Journal of Surgical Research 116(2) (2004), 337-349.
12. P. Somasundar, K.A. Frankenberry, H. Skinner et al., Prostate cancer cell proliferation is influenced by leptin, Journal of Surgical Research 118(1) (2004), 71-82.
13. K.A. Frankenberry, P. Somasundar, D.W. McFadden and L.C. Vona-Davis, Leptin induces cell migration and the expression of growth factors inhuman prostate cancer cells, The American Journal of Surgery 188(5) (2004), 560-565.
14. M. Onuma, J.D. Bub, T.L. Rummel and Y. Iwamoto, Prostate cancer cell-adipocyte interaction: leptin mediates andro-genindependent prostate cancer cell proliferation through c-Jun NH2-terminal kinase, Journal of Biological Chemistry 278(43) (2003), 42660-42667.
15. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, J.M. Friedman, Positional cloning of the mouse obese gene and its human homologue, Nature 372 (1994), 425-432.
16. R.V. Considine, M.K. Sinha, M.L. Heiman et al., Serum immunoreactive-leptin concentrations in normal-weight and obese humans, N Engl J Med 334 (1996), 292-295.
17. S.J. Nazian and D.F. Cameron, Temporal relation between leptin and various indices of sexual maturation in the male rat, J Androl 20 (1999), 487-491.
18. M.R. Hoda and G. Popken, Mitogen and anti-apoptotic actions of adipocyte derived hormone leptin in prostate cancer cells, BJU Int 102 (2008), 383-388.
19. M.S. Honigman, A.K. Nath, C. Murkani et al., Biological action of leptin as an angiogenic factor, Science 281 (1988), 1683-1686.
20. R. Grade-Andavolu, L.A. Cone, S. Shu et al., Molecular interactions of leptin and prostate cancer, Cancer J 12 (2006), 201-206.
21. J. Baillargeon, E.A. Platzc, D.P. Rose, B.H. Pollock, D.P. Ankerst, S. Haffner et al., Obesity, Adipokines, and Prostate Cancer in a Prospective Population-Based Study, Poster Abstracts, Cancer Biomarkers 2 (2006), 179-217.